Safety and Efficacy of HL Tablet in Non-alcoholic Fatty Liver Disease Patients

NCT02491905 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

69

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-alcoholic Fatty Liver Disease

Interventions

DRUG: HL tablet
DRUG: Placebo

Sponsor

Huons Co., Ltd.